| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/28/2002 | WO2000050566A3 Genes encoding insect odorant receptors and uses thereof |
| 02/28/2002 | US20020026651 Pathogenic tau mutations |
| 02/28/2002 | US20020026649 Metastasis models using green fluorescent protein (GFP) as a marker |
| 02/28/2002 | US20020026235 Prosthetic grafts |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026040 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020025939 Chorionic gonadortropin dna vaccines and methods |
| 02/28/2002 | US20020025577 Eukaryotic gene expression cassette and uses thereof |
| 02/28/2002 | US20020025559 Nucleotide sequences for use in the diagnosis and treatment of hypertension, heart, and kidney defects |
| 02/28/2002 | US20020025551 Novel molecules of the t129-related protein family and uses thereof |
| 02/28/2002 | US20020025550 Methods for producing highly phosphorylated lysosomal hydrolases |
| 02/28/2002 | US20020025540 Isolation of functionally active gamma- secretase protein complex and methods for detection of activity and Inhibitors thereof |
| 02/28/2002 | US20020025517 Methods and compositions for cellular and metabolic engineering |
| 02/28/2002 | US20020025516 Nrde |
| 02/28/2002 | US20020025511 Laser cell purification system |
| 02/28/2002 | US20020025317 For therapy and prophylaxis of pathological condition associated with expression of Interelukin-12 and/or Interleukin-18, including excessive or inappropriate amounts of those cytokines |
| 02/28/2002 | US20020025308 Composition for the delivery of live cells and methods of use |
| 02/28/2002 | US20020025306 Providing a source of a glucoincretin that increases the responsiveness of the cell to glucose |
| 02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
| 02/28/2002 | DE10036469A1 Ultraspiracle (USP)-Protein von Heliothis virescens Ultraspiracle (USP) protein of Heliothis virescens |
| 02/28/2002 | CA2674888A1 Anti-ige vaccines |
| 02/28/2002 | CA2674838A1 Anti-ige vaccines |
| 02/28/2002 | CA2456008A1 Stem cell differentiation |
| 02/28/2002 | CA2421062A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | CA2421059A1 Constructs and their use in metabolic pathway engineering |
| 02/28/2002 | CA2421057A1 Methods and reagents for molecular cloning |
| 02/28/2002 | CA2420901A1 Scaffolds for tissue engineered hair |
| 02/28/2002 | CA2420490A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/28/2002 | CA2420482A1 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | CA2420328A1 Synthetic nucleic acid molecule compositions and methods of preparation |
| 02/28/2002 | CA2420325A1 Plant polynucleotides encoding novel prenyl proteases |
| 02/28/2002 | CA2420261A1 Genes and proteins, and their uses |
| 02/28/2002 | CA2420260A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 02/28/2002 | CA2420257A1 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | CA2420233A1 Method for identifying substances useful for treating inflammation using the response element to the i.kappa.b.alpha. ror receptor |
| 02/28/2002 | CA2420198A1 Calycins |
| 02/28/2002 | CA2420101A1 Kidney-specific protein |
| 02/28/2002 | CA2420087A1 Cripto tumour polypeptide |
| 02/28/2002 | CA2420071A1 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | CA2420054A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | CA2419923A1 Vascularised tissue graft |
| 02/28/2002 | CA2419919A1 Novel imidazoline receptor homologs |
| 02/28/2002 | CA2419872A1 Identification of a human n-terminal acetyltransferase gene |
| 02/28/2002 | CA2419810A1 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | CA2419029A1 Bacillus thuringiensis crystal protein hybrids |
| 02/28/2002 | CA2418127A1 Transgenic plants with enhanced phenotypic properties and methods for producing them |
| 02/28/2002 | CA2417787A1 Lipid metabolism enzymes |
| 02/28/2002 | CA2417186A1 Microtubule-associated proteins and tubulins |
| 02/28/2002 | CA2415182A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | CA2388061A1 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | CA2356124A1 Anti-ige vaccines |
| 02/27/2002 | EP1182259A1 Pyruvate:NADP+ oxidoreductase and uses thereof |
| 02/27/2002 | EP1182257A1 Nucleic acids encoding dihydroflavonol 4-reductase with altered specificity and uses thereof |
| 02/27/2002 | EP1182253A2 Method for improving the thermostability of proteins |
| 02/27/2002 | EP1182250A2 Apparatus, systems and methods for microinjection of samples into amphibian oocytes |
| 02/27/2002 | EP1182213A1 Hybrid enzyme and use thereof |
| 02/27/2002 | EP1182212A2 Ultraspiracle USP-protetin of Heliothis virescens |
| 02/27/2002 | EP1181938A2 Rapamycin conjugates and antibodies |
| 02/27/2002 | EP1181549A1 Protein-protein interactions |
| 02/27/2002 | EP1181524A2 Method for enriching or depleting tumour cells obtained from a body fluid and kit suitable for this purpose |
| 02/27/2002 | EP1181390A1 27 human secreted proteins |
| 02/27/2002 | EP1181385A2 Modulation of gene expression in gastrointestinal inflammation |
| 02/27/2002 | EP1181373A1 Delta6-acetylenase and delta6-desaturase from ceratodon purpureus |
| 02/27/2002 | EP1181372A2 Viral expression vectors |
| 02/27/2002 | EP1181369A1 Four-helical bundle protein zsig81 |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181366A1 Mammalian receptor proteins; related reagents and methods |
| 02/27/2002 | EP1181365A1 PrP-LIKE GENE |
| 02/27/2002 | EP1181364A1 Lipid metabolism transcription factor |
| 02/27/2002 | EP1181355A2 A device and method for performing a biological modification of a fluid |
| 02/27/2002 | EP1181354A1 Method for multiplying stem cells |
| 02/27/2002 | EP1181353A1 Inducible packaging cell lines for lentivirus vectors |
| 02/27/2002 | EP1181352A1 Versican and epithelial-mesenchymal interaction |
| 02/27/2002 | EP1181323A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 02/27/2002 | EP1181320A2 Somatic transgene immunization and related methods |
| 02/27/2002 | EP1181319A1 Dr4 antibodies and uses thereof |
| 02/27/2002 | EP1181318A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 02/27/2002 | EP1181317A1 An integrin heterodimer and an alpha subunit thereof |
| 02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 02/27/2002 | EP1181312A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 02/27/2002 | EP1181306A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/27/2002 | EP1181305A1 Methods of modulating activity of prokaryotic ribosomes |
| 02/27/2002 | EP1181303A1 50 human secreted proteins |
| 02/27/2002 | EP1181056A1 Lim mineralization protein splice variants |
| 02/27/2002 | EP1181050A1 Methods for preventing reactivation of latent virus and controlling virus replication |
| 02/27/2002 | EP1181037A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 02/27/2002 | EP1181031A1 Novel antiangiogenic peptides |
| 02/27/2002 | EP1181025A2 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
| 02/27/2002 | EP1180999A2 Recombinant vaccine against botulinum neurotoxin |
| 02/27/2002 | EP0932689B1 Assays for homocysteine and homocysteine desulphurase from protozoan trichomonasvaginalis |
| 02/27/2002 | EP0858509B1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 02/27/2002 | EP0836380B1 Fgf9 as a specific ligand for fgfr3 |
| 02/27/2002 | EP0831887B1 Therapy using lymphotoxin and thrombopoietin |
| 02/27/2002 | EP0827545B1 Retroviral vectors |
| 02/27/2002 | EP0598029B1 Retroviral vectors containing internal ribosome entry sites |
| 02/27/2002 | EP0536330B1 Glyphosate tolerant plants |
| 02/27/2002 | CN1338000A Inducible expression system for use in plants |
| 02/27/2002 | CN1337467A Cell culture process of producing Xinjiang Saussurea involucrate general flavone |
| 02/27/2002 | CN1337465A Gene sequency of specific dihydro-flavonol4-reducing enayme as code substrate and its use thereof |